Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 268

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis

Jeong, Hoibin, Kim, Sehui, Hong, Beom-Ju, Lee, Chan-Ju, Kim, Young-Eun, Bok, Seoyeon, Oh, Jung-Min, Gwak, Seung-Hee, Yoo, Min Young, Lee, Min Sun, Chung, Seock-Jin, Defrêne, Joan, Tessier, Philippe, Pelletier, Martin, Jeon, Hyeongrin, Roh, Tae-Young, Kim, Bumju, Kim, Ki Hean, Ju, Ji Hyeon, Kim, Sungjee, Lee, Yoon-Jin, Kim, Dong-Wan, Kim, Il Han, Kim, Hak Jae, Park, Jong-Wan, Lee, Yun-Sang, Lee, Jae Sung, Cheon, Gi Jeong, Weissman, Irving L., Chung, Doo Hyun, Jeon, Yoon Kyung, Ahn, G-One·2019·Cancer Research

Abstract

Tumor hypoxia and aerobic glycolysis are well-known resistance factors for anticancer therapies. Here, we demonstrate that tumor-associated macrophages (TAM) enhance tumor hypoxia and aerobic glycolysis in mice subcutaneous tumors and in patients with non–small cell lung cancer (NSCLC). We found a strong correlation between CD68 TAM immunostaining and PET 18fluoro-deoxyglucose (FDG) uptake in 98 matched tumors of patients with NSCLC. We also observed a significant correlation between CD68 and glycolytic gene signatures in 513 patients with NSCLC from The Cancer Genome Atlas database. TAM secreted TNFα to promote tumor cell glycolysis, whereas increased AMP-activated protein kinase and peroxisome proliferator-activated receptor gamma coactivator 1-alpha in TAM facilitated tumor hypoxia. Depletion of TAM by clodronate was sufficient to abrogate aerobic glycolysis and tumor hypoxia, thereby improving tumor response to anticancer therapies. TAM depletion led to a significant increase in programmed death-ligand 1 (PD-L1) expression in aerobic cancer cells as well as T-cell infiltration in tumors, resulting in antitumor efficacy by PD-L1 antibodies, which were otherwise completely ineffective. These data suggest that TAM can significantly alter tumor metabolism, further complicating tumor response to anticancer therapies, including immunotherapy. Significance: These findings show that tumor-associated macrophages can significantly modulate tumor metabolism, hindering the efficacy of anticancer therapies, including anti-PD-L1 immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-18-2545

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 268

Metadata

Authors
Jeong, H., Kim, S., Hong, B.-J., Lee, C.-J., Kim, Y.-E., Bok, S., Oh, J.-M., Gwak, S.-H., Yoo, M. Y., Lee, M. S., Chung, S.-J., Defrêne, J., Tessier, P., Pelletier, M., Jeon, H., Roh, T.-Y., Kim, B., Kim, K. H., Ju, J. H., Kim, S., Lee, Y.-J., Kim, D.-W., Kim, I. H., Kim, H. J., Park, J.-W., Lee, Y.-S., Lee, J. S., Cheon, G. J., Weissman, I. L., Chung, D. H., Jeon, Y. K., & Ahn, G.-O.
Venue
Cancer Research
Published
2019-02-15
Volume
79
Issue
4
Pages
795-806
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2908456822
Cited by
268
References
50
FWCI
11.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis. https://app.cochat.ai/papers/10.1158/0008-5472.can-18-2545
The paper
Jeong, H., Kim, S., Hong, B.-J., Lee, C.-J., Kim, Y.-E., Bok, S., Oh, J.-M., Gwak, S.-H., Yoo, M. Y., Lee, M. S., Chung, S.-J., Defrêne, J., Tessier, P., Pelletier, M., Jeon, H., Roh, T.-Y., Kim, B., Kim, K. H., Ju, J. H., . . . Ahn, G.-O. (2019). Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis. Cancer Research. https://doi.org/10.1158/0008-5472.can-18-2545

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.